Trump extends most-favored-nation drug pricing to Medicaid in all 50 states, citing $64bn in savings

President Trump announced that his discounted most-favored-nation drug pricing is being extended to Medicaid in all 50 states, a move he said will affect 70 million Americans and save Medicaid over $64 billion, per CEA estimates. The administration says it has secured MFN agreements with 26 of the world's largest drugmakers covering 90% of drugs.

Detected & updated continuously · Source: Nebula